FDA Chairman - Search News

News

FDA approves HIV prevention drug taken

FDA approves HIV prevention drug taken as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Yahoo Finance · 2h

Gilead Sciences’ Yeztugo receives approval from US FDA for HIV

The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a pre-exposure prophylaxis (PrEP) against HIV. It is the first and only biannual PrEP option available in the US for adults and adolescents weighing at least 35kg.

CNN on MSN · 16h

FDA approves twice-a-year injection for HIV prevention

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

FDA Approves Medicine Reducing Risk Of Acquiring AIDS By Almost 100 Pct

The US Food and Drug Administration (FDA) has approved a medicine that would reduce the risk of acquiring HIV in adult ...

17hon MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML

Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer ...

Managed Healthcare Executive17h

FDA Approves Hereditary Angioedema Therapy, Andembry

CSL Behring’s Andembry is now approved as a subcutaneous, self-injection for hereditary angioedema (HAE) patients ages 12 and older and will be available by the end of June 2025.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results